VanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 33.8% in August

VanEck Biotech ETF (NASDAQ:BBH) was the recipient of a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 21,252 shares, a drop of 33.8% from the August 15th total of 32,083 shares. Based on an average trading volume of 10,054 shares, the short-interest ratio is presently 2.1 days. Currently, 1.0% of the company’s shares are short sold.

Insider Buying and Selling

In related news, major shareholder Sardar Biglari sold 6,533 shares of VanEck Biotech ETF stock in a transaction dated Wednesday, July 15th. The shares were sold at an average price of $16.71, for a total transaction of $109,166.43. Following the completion of the sale, the insider owned 3,552,710 shares in the company, valued at $59,365,784.10. This trade represents a 0.18% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Over the last 90 days, insiders sold 10,493 shares of company stock valued at $175,335.

Institutional Investors Weigh In On VanEck Biotech ETF

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Allworth Financial LP grew its position in VanEck Biotech ETF by 255.0% during the 4th quarter. Allworth Financial LP now owns 426 shares of the company’s stock worth $81,000 after purchasing an additional 306 shares during the last quarter. First PREMIER Bank purchased a new position in shares of VanEck Biotech ETF in the second quarter worth $91,000. JNBA Financial Advisors acquired a new position in shares of VanEck Biotech ETF in the 2nd quarter valued at $122,000. Fifth Third Bancorp acquired a new position in shares of VanEck Biotech ETF in the 1st quarter valued at $127,000. Finally, Huntington National Bank purchased a new position in VanEck Biotech ETF in the 4th quarter worth $132,000. Hedge funds and other institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Performance

BBH opened at $237.00 on Friday. VanEck Biotech ETF has a 52 week low of $160.91 and a 52 week high of $244.35. The stock’s fifty day moving average is $221.91 and its two-hundred day moving average is $200.99.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.